Previous 10 | Next 10 |
Fiscal first quarter 2023 revenue of $85.5 million, a 44% increase compared to fiscal first quarter 2022 revenue of $59.5 million SEATTLE, June 30, 2022 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal first quarter ended May 31, 2...
Gainers: Seres Therapeutics (MCRB) +8%. Sana Biotechnology (SANA) +5%. Aziyo Biologics (AZYO) +4%. eXp World Holdings (EXPI) +4%. Aurora Innovation (AUR) +3%. Losers: Trip.com Group (TCOM) -9%. Xenon Pharmaceuticals (XENE) -8%. Accolade (ACCD) -6%. Ikena Oncology (IKNA) -6%. Cerus (...
Accolade to showcase Personalized Healthcare for health plans at AHIP 2022 PR Newswire Accolade and Priority Health will discuss how Personalized Healthcare can deliver value for health plans seeking virtual first solutions for whole person care. SEATTLE ...
SEATTLE, June 21, 2022 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves over 600 employers and millions of members, today announced that it will release fiscal first quarter 2023 financial results on Thursday, June 30, 2022, after the market closes. ...
Gainers: Rent the Runway (RENT) +10%. BioAtla (BCAB) +9%. Adaptive Biotechnologies Corporation (ADPT) +5%. Accolade (ACCD) +5%. Nurix Therapeutics (NRIX) +5%. Losers: DocuSign (DOCU) -23%. Stitch Fix (SFIX) -16%. Comtech Telecommunications (CMTL) -15%. View (VIEW) -12%. DBV Te...
SEATTLE, June 02, 2022 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will participate in the following upcoming investor conferences. A webcast and replay of each event will be available at ir.accolade.com. Wednesday, June 8 at 4:10 pm ET . Stifel 202...
Gainers: Fanhua (FANH) +7%. Ocular Therapeutix (OCUL) +5%. ThredUp (TDUP) +5%. Cara Therapeutics (CARA) +3%. LegalZoom.com (LZ) +3%. Losers: Eton Pharmaceuticals (ETON) -21%. Allakos (ALLK) -7%. Accolade (ACCD) -5%. Sono Group (SEV) -5%. FTC Solar (FTCI) -4%. For furth...
Accolade Expands Mental Health Integrated Care Offering to Adolescents and Teens PR Newswire Accolade and Headspace Health to increase access to preventative resources and mental health services for adolescents and teens amid national mental health crisis SEA...
SEATTLE, May 09, 2022 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will participate in the following upcoming investor conferences. A webcast and replay of each event will be available at ir.accolade.com. Thursday, May 12 at 1pm ET . BofA Securities ...
Accolade Launches Medication Integrated Care to Address Prescription Drug Costs and Complications PR Newswire Medication Integrated Care combines pharmacist-led medication therapy management with advanced analytics powered by Rx Savings Solutions to help employers reac...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, NY / ACCESSWIRE / July 15, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...
NEW YORK, NY / ACCESSWIRE / July 11, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...
A look at the top 10 most actives in the United States Innovative Eyewear Inc. (LUCY) rose 50.0% to $0.495 on volume of 360,218,139 shares NVIDIA Corporation (NVDA) fell 0.4% to $123.54 on volume of 307,578,749 shares Ginkgo Bioworks Holdings Inc. Class A (DNA) rose 8.1% to $0.3343 on vol...